Wednesday, February 10, 2010, 5:51am EST - Canadian Markets open in 3 hours and 39 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

GENENTECH INC (DNA)

 On Nov 17: 80.43 USD   0.00 (0.00%)  
MORE ON DNA
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
GENENTECH INC (NYSE:DNA) Delayed quote dataEdit
Last Trade: 80.43 USD
Trade Time: Nov 17
Change: 0.00 (0.00%)
Prev Close: 80.43
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: 96.89
Day's Range: N/A - N/A
52wk Range: 69.17 - 99.14
Volume: 0
Avg Vol (3m): 0
Market Cap: N/A
P/E (ttm): N/A
EPS (ttm): N/A
Div & Yield: N/A (N/A%)
GENENTECH INC (DNA)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add DNA to Portfolio   Download Data

HEADLINES
• UPDATE - Sanofi says vaccines to help lift 2010 earnings
at Reuters (Wed 3:00am)
• Researchers find sex-specific lung cancer genes
at Reuters (Tue 7:34pm)
• Seattle Genetics 4Q loss narrows on higher revenue
AP (Tue 6:18pm)
• UPDATE - Biogen 4th-qtr profit up, outlook tops estimates
at Reuters (Tue 11:32am)
• UPDATE - Roche licenses new flu-fighting technology
at Reuters (Mon, Feb 8)
• Stocks for the Next Decade
at Motley Fool (Thu, Feb 4)
• UPDATE - Glaxo drops some drug research in efficiency drive
at Reuters (Thu, Feb 4)
• Drugmakers Pfizer, Roche disappoint with forecasts
at Reuters (Wed, Feb 3)
• Genentech share deal weighs on Roche
at FT.com (Wed, Feb 3)
• UPDATE - Roche profit misses forecast but confirms outlook
at Reuters (Wed, Feb 3)
More Headlines for DNA...
ANALYST
EPS Est (next year) (Dec-09) : N/A
EPS Est (in 2 years) (Dec-10) : N/A
Avg Rec (current)*: 2.8
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
No business summary available for DNA.


Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices